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■ Summary Background Many
different mechanisms are involved
in nutrient-related prevention of
colon cancer. In this study, a com-
prehensive assessment of the spec-
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trum of possible biological actions
of the bioactive compound
quercetin is made using multiple
gene expression analysis. Quercetin
is a flavonoid that can inhibit pro-
liferation of tumor cells and reduce
the number of aberrant crypt foci,
although increase of number of
colon tumors was also reported.
Aim of the study In order to eluci-
date possible mechanisms involved
in its mode of action the effect of
quercetin on expression of 4000
human genes in Caco-2 cells was
studied and related to functional
effects. Methods Caco-2 cells were
exposed to 5 or 50 µM quercetin for
48 hours, differential expression of
4000 human genes was studied us-
ing microarrays and related to
functional effects. Differentially ex-
pressed genes were categorized in
seven functional groups: cell cycle
and differentiation, apoptosis, tu-
mor suppressor genes and onco-
genes, cell adhesion and cell-cell
interaction, transcription, signal
transduction and energy metabo-
lism. Also, cell proliferation and
cell cycle distribution were mea-
sured. Results Quercetin (5 µM)
downregulated expression of cell
cycle genes (for example CDC6,
CDK4 and cyclin D1), downregu-
lated cell proliferation and induced
cell cycle arrest in Caco-2 cells. Af-
ter exposure to 50 µM quercetin
cell proliferation decreased to
51.3 % of control, and further de-
crease of the percentage of cells in
the G1 phase coincided with an in-
crease of the percentage of cells in
the sub-G1 phase. Quercetin upreg-
ulated expression of several tumor
suppressor genes. In addition,
genes involved in signal transduc-
tion pathways like beta catenin/
TCF signalling and MAPK signal
transduction were influenced by
quercetin. Conclusions This study
shows that large-scale gene expres-
sion analysis in combination with
functional assays yields a consider-
able amount of information on
(anti-)carcinogenic potential of
food components like quercetin.
■ Key words quercetin – Caco-2 –
gene expression – cell proliferation
– (anti-)carcinogenic mechanisms
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expression analysis of quercetin bioactivity
on anticancer-related mechanisms 
in colon cancer cells in vitro
Introduction
Diet plays an important role both in the development
and prevention of colon cancer. Many food components
have been reported to protect against colon cancer
through a variety of (proposed) mechanisms. However,
a body of seemingly conflicting evidence on these food
bioactives has been published, suggesting that elucida-
tion of colon cancer-preventive mechanisms is not al-
ways straightforward. Depending on dose levels, uptake
rates and also the model used different results can be ob-
tained. New techniques, like multiple gene expression
analysis employing microarrays, allow for a more com-
EJN
 503
143-156_Erk_EJN_503  08.03.2005  13:09 Uhr  Seite 143
144 European Journal of Nutrition (2005) Vol. 44, Number 3
© Steinkopff Verlag 2004
prehensive study of the effects and mechanisms of food
components.By using cDNA microarrays the expression
of thousands of genes can be studied in one experiment.
The power of these techniques lies in the fact that a large
set of real experimental data is acquired, which can re-
sult in leads to pathways and mechanisms, as opposed to
the extrapolation of assessments of a few genes. Mi-
croarrays have been used for example to study gene ex-
pression profiles of human colon cancer biopsies from
different disease stages [1], and of colon cancer cells af-
ter exposure to NSAIDs and butyrate [2, 3]. Such exper-
iments will lead to a better understanding of the process
of colon carcinogenesis and of prevention of colon can-
cer development by food components.
Quercetin is a well-known flavonoid present in
plants, consumed in relatively high amounts [4] and
with multiple health effects. Quercetin is a potent anti-
oxidant and has presumed anti-inflammatory effects.
Quercetin has shown a range of effects in in vitro and in
vivo studies. In rats, quercetin has been found to reduce
the number of aberrant crypt foci (ACF) after chemical
induction of tumor formation [5, 6], but quercetin has
also been reported to dose-dependently increase the
number of colon tumors after azoxymethane (AOM) in-
jection [7]. In mice, quercetin reduced the number of fo-
cal areas of dysplasia (FAD) induced by AOM [8, 9] and
also the number of colon tumors and tumor multiplic-
ity [8].However,when quercetin was administered with-
out AOM, it caused an increase in FADs in mice [9]. In
mice with a germline APC mutation, quercetin had no
effect on intestinal tumor formation [10]. Thus,
quercetin displayed both anti-carcinogenic and carcino-
genic properties, depending on model and concentra-
tion used.
Quercetin was shown to inhibit growth of tumor cells
in vitro [11, 12], can be cytotoxic for actively proliferat-
ing cells [13] and can cause undifferentiated cancer cell
lines to differentiate [14]. Quercetin is unstable in cell
culture media and disappears quickly [15]. Kuo et al.
found that quercetin was unstable, but still exerted an
antiproliferative effect in Caco-2 and HT29 cells, which
in part may be caused by its metabolites [12]. Murota
et al. showed that in Caco-2 cells quercetin is efficiently
absorbed and metabolized [16].
In bacteria quercetin has mutagenic potential, as was
shown by Bjeldanes [17]. In Caco-2 cells however,
quercetin did not cause DNA strand breaks [18]. Several
in vitro studies showed that quercetin can protect
against hydrogen peroxide induced DNA strand breaks
in Caco-2 cells [19, 20].
In fruits and vegetables quercetin is present as a gly-
coside (bound to sugar).To some extent these glycosides
can be absorbed in the small intestine. The glycosides
that reach the colon are hydrolyzed by the colonic mi-
croflora [4]. The large intestine can thus be exposed to
relatively high concentrations of quercetin.Recently,van
der Woude et al. stated that concentration of free
quercetin can reach up to 100 µM in the intestinal lumen
after ingestion of a quercetin supplement (250–500 mg)
[21].
Thus, quercetin has a broad range of effects in colon
cancer cells, but the exact mechanism is unknown.
Studying the effect of quercetin on expression of thou-
sands of genes is likely to give more insight into the
bioactive mechanisms of this flavonoid. Therefore, in
this study the effect of quercetin on expression of 4000
genes in human colon cancer cells is studied, simultane-
ously analyzing cell cycle, apoptosis, cell adhesion, tran-
scription, signal transduction and tumor suppressor
gene and oncogene responses to quercetin. In addition,
to demonstrate the physiological relevance of the pre-
sented gene expression data cell proliferation and cell
cycle distribution were measured, as cancer-related
physiological end-points.
Materials and methods
■ Cell culture
Caco-2 cells (passage 38) (ATCC, Rockville, USA) were
grown in DMEM with 25mM HEPES,10 % FCS,1 % non-
essential amino acids, 2 mM L-glutamine and 50 µg/ml
gentamicine. After seeding, cells reached 100 % conflu-
ency in 7 days. Cells were maintained at 37 °C in a hu-
midified atmosphere containing 5 % CO2. Quercetin
(Sigma, St. Louis, MO, USA) was dissolved in ethanol.
Caco-2 cells were exposed to 5 or 50 µM quercetin, or
only to ethanol (solvent). The final concentration of
ethanol in the culture medium was 1 %. After 24 hours,
fresh medium and quercetin were added to the cells, and
24 hours later cells were trypsinized and flash frozen in
liquid nitrogen. All incubations were performed in qua-
druplicate. After 48 hours exposure, cells were counted
and cytotoxicity was assessed using Trypan Blue exclu-
sion.
■ Cell proliferation
After exposure of confluent Caco-2 cells to quercetin,
cell proliferation was measured using an ELISA-BrdU-
kit (Roche Diagnostics GmbH) to quantify bromodeoxy
uridine (BrdU) incorporation. Absorbance at 370 nm
was corrected for absorbance at 492 nm. In addition, this
value was corrected for background absorbance. Ab-
sorbance of cells exposed to ethanol (solvent) was set to
100 %.
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■ Cell cycle analysis using flow cytometry
After exposure of confluent Caco-2 cells to quercetin,
cells were trypsinized and washed with PBS. Ice-cold
ethanol (75 %) was added to the cells while vortexing,
and cells were incubated on ice for 1 hour. Cells were
washed with PBS and finally PBS with propidium iodide
(Sigma; 50 µg/ml) and Rnase A (Qiagen, Hilden, Ger-
many; 0.1 mg/ml) was added. After incubation for 30
min in the dark, cells were analyzed using an Epics XL-
MCL flow cytometer (Beckman Coulter). P-values for
difference between cell cycle distribution in cells ex-
posed to ethanol and in cells exposed to quercetin were
calculated using a t-test.
■ RNA isolation
Total RNA was isolated from the cell pellets using Trizol
(Life Technologies S. A., Merelbeke, Belgium) according
to the manufacturer’s protocol. RNA was checked for
purity and stability by 1 % agarose gel electrophoresis
and UV spectrometry. Absorption at 260 and 280 nm
was measured spectrophotometrically and RNA quan-
tity and A260/280 ratio were calculated. Only RNA samples
with A260/280 ratio > 1.6 were used in further experi-
ments.
■ cDNA microarray preparation
A set of about 4100 sequence-verified human cDNA
clones from the I. M. A. G.E. consortium was purchased
(Research Genetics, U. S. A.) as PCR products. The am-
plified cDNA was re-amplified by PCR with forward (5’
-CTGCAAGGCGATTAAGTTGGGTAAC-3’) and reverse
(5’-GTGAGCGGATAACAATTTCACACAGGAAACAGC-
3’) primers. The primers contained a 5’- C6-aminolinker
(Isogen Bioscience, Maarsen, The Netherlands) to facil-
itate crosslinking to the aldehyde coated glass micro-
scope slides. PCR products were checked by elec-
trophoresis on a 1 % agarose gel. PCR products were
purified by isopropanol precipitation and washing in
70 % ethanol, and were dissolved in 3 x SSC. The clones
were spotted in duplicate on CSS-100 silylated aldehyde
glass slides (TeleChem, Sunnyvale, CA, USA) in a con-
trolled atmosphere. To reduce free aldehyde residues,
slides were blocked with borohydride after spotting and
drying. Slides were stored at room temperature in the
dark and dust-free until further use.
■ Quantitative real-time polymerase chain reaction
2 µg of total RNA was reverse transcribed into cDNA us-
ing 250 ng random hexamer primers and 200 units M-
MLV reverse transcriptase (Invitrogen Life Technolo-
gies, Breda, the Netherlands) in a final volume of 20 µl.
The same batch of cDNA was used for all real-time PCR
experiments. Real-time PCR was performed using an
iCycler PCR machine (Biorad, Veenendaal, the Nether-
lands) and the QuantiTect SYBR Green PCR kit (Qiagen,
Hilden,Germany).For all types of amplicon primer con-
centration was 400 nM and reactions were performed in
a final volume of 25 µl containing primers, cDNA and 1x
QuantiTect SYBR Green Master Mix (Qiagen, Hilden,
Germany). GAPDH and beta-actin expression was mea-
sured to correct for differences in efficiency during re-
verse transcription. The primer pairs used to amplify
beta-actin, GAPDH, RALA, CDK4 and CYP1A1 were as
follows: beta-actin upstream: 5’-CAC CCC GTG CTG
CTG AC-3’, downstream: 5’-CCA GAG GCG TAC AGG
GAT AG-3’; GAPDH upstream: 5’-TGC ACC ACC AAC
TGC TTA GC-3’, downstream: 5’-GGC ATG GAC TGT
GGT CAT GAG-3’; RALA upstream: 5’-GGT CAG AAT
TCT TTG GCT TTA CAC A-3’, downstream: 5’-CTC CCC
ATC TAG CAC TAC CTT CTT C-3’; CDK4 upstream: 5’-
GAG GCC TTC CCA TCA GCA CAG TTC-3’, down-
stream: 5’-TCA AAA GCC TCC AGT CGC CTC AGT A-3’;
CYP1A1 upstream: 5’- CCA TGT CGG CCA CGG AGT
TTC-3’, downstream: 5’- CAT GGC CCT GGT GGA TTC
TTC A-3’.
Before real-time PCR analyses, the correct size of the
obtained PCR products was checked by gel elec-
trophoresis. At the end of all real-time PCR runs, a melt
curve peak analysis was performed to ensure amplifica-
tion of only the correct product.
For each gene 6 dilutions of cDNA (equivalent to 100,
50, 25, 12.5, 6.25, 3.12 ng of starting RNA) were run in
triplicate to determine PCR efficiency per sample. A
threshold was chosen so that amplification was in the
exponential phase and the correlation coefficient (as
found for the linear relation between threshold cycle
value and log of starting quantity) was maximal. The av-
erage threshold cycle for triplicate measurements was
used to calculate expression ratios. Differences in ex-
pression between the exposed samples and the control
sample were tested for significance using Mann-Whit-
ney U-test (P < 0.05).
■ Labelling and hybridization
RNA was labeled indirectly using a modification of the
aminoallyl labeling method from DeRisi lab (www.mi-
croarrays.org). 25 µg of total RNA was reverse tran-
scribed with Superscript II reverse transcriptase (Invit-
rogen Life Technologies, Breda, the Netherlands), in the
presence of aminoallyl-dUTP (Sigma, St. Louis, MO,
USA) which was built into the cDNA. The reaction mix-
ture was incubated at 42 °C for one hour. After cDNA
synthesis, RNA was removed by adding Rnase (15 min,
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37 °C) and the resulting cDNA was purified using QI-
Aquick spin columns (Qiagen, Hilden, Germany). The
cDNA was dried and resuspended in 5 µl water. To cou-
ple Cy3 or Cy5 to the amino-modified cDNA, sodium bi-
carbonate and NHS-Cy3 or NHS-Cy5 (Amersham Bio-
sciences, Freiburg, Germany) were added to the cDNA
and incubated for 1 hour. Uncoupled dye was removed
from the solution by purification with QIAquick spin
columns. cDNA from cells exposed to 5 or 50 µM
quercetin was labeled with Cy3 and cDNA from cells ex-
posed to ethanol (solvent control, 0 µM quercetin) was
labeled with Cy5.
Before hybridization, Cy3- and Cy5-labeled cDNAs
were mixed and human cot-1 DNA (30 µg, Life Tech-
nologies S. A., Merelbeke, Belgium), yeast tRNA (100 µg,
Life Technologies S. A., Merelbeke, Belgium) and
poly(dA-dT) (20 µg, Amersham Biosciences, Freiburg,
Germany) were added to avoid non-specific binding.
The hybridization mix was dissolved in 30 µl Easyhyb
hybridization buffer (Roche Diagnostics, Mannheim,
Germany) and denatured for 1.5 min at 100 °C.
Before adding the hybridization mix to the slides,
slides were prehybridized in prehybridization buffer (5
x SSC, 0.1 % SDS and bovine albumine serum
(10 mg/ml)) for 2 hours at 42 °C, washed in milliQ water,
washed with isopropanol and dried.
After pipetting the hybridization mix on the slides,
the slides were covered with a plastic coverslip and hy-
bridized overnight in a slide incubation chamber (Corn-
ing,Life Sciences,Schiphol, the Netherlands) submerged
in a 42 °C waterbath. After hybridization, slides were
washed once by firm shaking in 2 x SSC buffer with 1 %
SDS followed by firm shaking in 0.1 x SSC buffer twice,
then slides were dried quickly by centrifugation at 700
rpm.
Slides were scanned with a ScanArray 4000 (Perkin
Elmer Life Sciences, USA) and Imagene 4.0 (Biodiscov-
ery Inc.,Los Angeles,USA) was used to extract data from
the images. For each comparison (5 vs 0 µM quercetin
and 50 vs 0 µM quercetin) 4 hybridizations were per-
formed.
■ Data analysis
Data were transferred from Imagene to Microsoft Excel
97 (Microsoft Corporation, USA) for analysis. First, a
threshold was set for signal/background ratio in both
channels,based on measured fluorescence of spots with-
out cDNA. About 10–25 % of the spots had fluorescence
below this threshold in one or both channels and were
excluded from data analysis. Then, local background in-
tensity was subtracted from mean signal intensity and
expression ratios were calculated by dividing back-
ground corrected signal intensity for Cy3 by back-
ground corrected signal intensity for Cy5. Since all cD-
NAs were present twice on each slide, mean expression
ratios for duplo spots were calculated, provided that ex-
pression ratios were calculated for both spots. Mean ex-
pression ratios were log transformed (base 2) and nor-
malized (for each slide) using an intensity-dependent
method (Lowess) [22]. After normalization, data from
the 4 duplo slides were combined and for each gene a
mean expression ratio for 5 vs 0 µM quercetin and for 50
vs 0 µM quercetin was calculated.
A subset of differentially expressed genes was de-
fined by selecting genes that were on the edges of the
data distribution (outliers, identified by correcting
mean expression ratios for spot intensity) or by using
the SAM tool, based on Tusher et al. [23], to select genes
that were in the top 100 for SAM scores. These methods
were chosen to ensure a low false discovery rate for the
genes identified as differentially expressed. In addition,
for all genes in this subset of differentially expressed
genes statistical significance was determined using a
Student’s T-test.
For all selected genes, the accession number was 
used to search the NCBI Unigene website
(www.ncbi.nlm.nih.gov/Unigene/) for the most recent
gene names. Information on the genes was obtained
from the NCBI websites UniGene, LocusLink, OMIM
and PubMed (www.ncbi.nlm.nih.gov). Although the
genes on the slides were ‘known’ genes and not ESTs, of
the selected genes about 40 accession numbers were at
this time unknown or returned an interim or not official
name. Also, for some genes function was unknown.
Results
The expression of most of the genes studied did not
change as a result of the treatment with quercetin. After
applying the criteria as described in materials and
methods, 150–200 differentially expressed genes were
selected in the 5 µM quercetin dataset and in the 50 µM
quercetin dataset.All selected genes had a mean expres-
sion ratio (log transformed, base 2) significantly differ-
ent from 0 (P < 0.05).
Genes were categorized in seven functional groups:
1) cell cycle and cell differentiation (Table 1), 2) apopto-
sis (Table 2), 3) tumor suppressor genes and oncogenes
(Table 3), 4) cell adhesion and cell-cell interaction
(Table 4), 5) transcription (Table 5), 6) signal transduc-
tion (Table 6) and 7) energy metabolism (Table 7).
Almost all of the differentially expressed genes in-
volved in cell cycle and differentiation (Table 1) were
downregulated, specifically in the 5 µM quercetin
dataset.For the majority of the genes this would indicate
inhibition of cell proliferation. However, PPP2R4 is im-
plicated to play a role in negative control of cell growth
and SIAH1 is a mediator of cell cycle arrest, tumor sup-
pression and apoptosis [24]. Genes involved in different
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phases of the cell cycle are downregulated, PWP2H has
a role in the early G1 phase, CDK4 and cyclin D1 are ac-
tive during the G1-S phase and M-phase phosphopro-
tein induces the transition from the G2 to M phase.Also,
genes involved in DNA replication (CDC6, POLA,
POLD2, RBMS1, RBMS2), in aligning chromosomes
(MAD2L1) and in chromosome segregation (ZW10)
were downregulated. Two histone family members
(HIST1H2AC and H1FX) were markedly downregulated
after exposure to 5 µM quercetin. Overexpression of
S100P is indicated to be important during tumor pro-
gression in vivo [25], this gene was downregulated by
5 µM quercetin.A few of the listed genes (RQCD1, PLAB,
S100P, FGF7) are involved in cell differentiation rather
than regulation of cell cycle progression. Quercetin at
50 µM upregulated FGF7 expression, upregulation of
FGF7 could indicate increased cell differentiation [26].
Expression of BUB1B (involved in mitotic checkpoint
control) was also upregulated by quercetin.
Table 2 lists genes involved in apoptosis that were dif-
ferentially expressed in Caco-2 cells in response to
quercetin. APAF1, downregulated by 5 µM quercetin, is
an important part of the caspase cascade. In response to
cytochrome c release from mitochondria APAF1 acti-
vates caspase-9, which results in activation of caspase-3.
In this study caspase-9 was downregulated by 50 µM
quercetin, although this effect did not meet the selection
criteria set for differential expression. Transcription of
caspase-1 (CASP1) was downregulated by 50 µM
quercetin. SERPINB9, also known as PI9, is an inhibitor
of CASP1 [27]. SERPINB9 and SERPINB3 were upregu-
lated by both quercetin concentrations, which is consis-
tent with the observed downregulation of CASP1. In
cDNA microarray analysis it was found that SFRP1,
downregulated by 50 µM quercetin, is methylated in
Caco-2 cells and also in most other colon cancer cell
lines, resulting in lower expression [28]. Expression of
TP53BP2 was upregulated by 5 µM quercetin.
Table 3 lists tumor suppressor genes and oncogenes.
Quercetin upregulated expression of two tumor sup-
Table 1 Expression changes of genes involved in cell cycle and cell differentiation
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
H59204 Cdc6 Cell division cycle 6 homolog CDC6 –4.17*, c
AA452933 Histone 1, H2ac HIST1H2AC –3.93*, d –2.41
W81318 H1 histone family, member X H1FX –3.16*, b
AA428377 Polymerase (DNA directed), δ2, regulatory subunit (50kD) POLD2 –3.10*, a
AA488188 RCD1 required for cell differentiation1 homolog (S. pombe) RQCD1 –2.88*, c –2.23*, a
AA460827 Protein phosphatase 1, regulatory (inhibitor) subunit 1A PPP1R1A –2.84*, c –4.06a
AA450062 Prostate differentiation factor PLAB –2.42*, a –2.65*, a
AA074222 Squamous cell carcinoma antigen recognized by T cells SART1 –2.38*, d –1.79
T72030 Seven in absentia homolog 1 (Drosophila) SIAH1 –2.39a –1.62
AA490617 Vaccinia related kinase 2 VRK2 –2.29*, c –1.69
R51209 protein phosphatase 2A, regulatory subunit B’ PPP2R4 –2.27*, c –1.43
H52729 PWP2 periodic tryptophan protein homolog (yeast) PWP2H –2.26a –1.53
AA708161 RNA binding motif, single stranded interacting protein 2 RBMS2 –2.18*, a –1.37
AA458870 CDC37 cell division cycle 37 homolog (S. cerevisiae) CDC37 –2.17a –1.61
AA282936 M-phase phosphoprotein 1 MPHOSPH1 –2.06c –1.39
AA599145 ZW10 homolog, centromere/kinetochore protein (Drosophila) ZW10 –2.03 –2.19*, c
AA456291 Developmentally regulated GTP binding protein 2 DRG2 –2.00a –2.08*, c
R32848 S100 calcium binding protein P S100P –1.82b 1.15
AA481076 MAD2 mitotic arrest deficient-like 1 (yeast) MAD2L1 –1.74*, c –1.61
N31587 RNA binding motif, single stranded interacting protein 1 RBMS1 –1.69a –1.60
AA486208 Cyclin-dependent kinase 4 CDK4 –1.63 –2.17b
AA629262 Polo-like kinase (Drosophila) PLK –1.55 –1.68*, c
AA707650 Polymerase (DNA directed), α POLA –1.52 –2.01*, a
AA487486 Cyclin D1 (PRAD1: parathyroid adenomatosis 1) CCND1 –1.47*, c –1.17
AA054287 RNA binding motif protein 3 RBM3 –1.37 –2.07*, c
AA488324 BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) BUB1B 1.51*, c 1.54*, d
AA009609 Fibroblast growth factor 7 (keratinocyte growth factor) FGF7 2.18*, d 2.40 *, a
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure. Values <0 indicate downregulation, values >0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01; d P < 0.001
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pressor genes, BRCA2 and MUC2. BRCA2 is reported to
have a role in DNA repair and thus to maintain chromo-
somal stability [29].Recently, it was concluded in a study
with MUC2–/– mice that MUC2 suppresses colorectal
cancer [30]. TSG101 is involved in growth and differen-
tiation control in epithelial cells [31].TIMP2 is known as
a metastasis suppressor. TSG101 and TIMP2 are also up-
regulated. CEACAM5 (at 5 µM) and RALA (at 5 and
50 µM) are downregulated by quercetin. RALA is a po-
tential stimulator of tumor metastasis [32]. Expression
of the proto-oncogene MYC was upregulated after expo-
sure to 50 µM quercetin.
Downregulation of genes involved in cell adhesion
and cell-cell interaction was found at both quercetin
concentrations (Table 4). Plakophilin 2 (downregulated
at 5 and 50 µM quercetin) has a function in intercellular
junctions. Overexpression of AOC3 was found in gastric
cancer [33], in this study AOC3 was downregulated by
5 µM quercetin. Several other cell adhesion genes were
upregulated, especially at the higher quercetin concen-
tration (50 µM).Among these genes are two cadherins (2
and 11) and alpha-catenin. Alpha-catenin was upregu-
lated at both quercetin concentrations. Downregulation
of alpha-catenin in colorectal cancer is a marker for
poor differentiation and high metastatic potential [34].
Cadherin 2, which also was upregulated by quercetin,
has been found to promote motility and invasion in
breast cancer cells [35]. Thrombospondin 2 can act as a
angioinhibiting factor and contribute to inhibition of
colon cancer metastasis [36].
Genes involved in transcription that were differen-
tially expressed in response to quercetin are shown in
Table 5. PAX8 has been reported to activate the BCL2-
promoter and to inhibit the p53-promotor, thus regulat-
ing expression of these genes [37, 38]. RELB is a member
of the NF-kappaB family and can regulate transcription
of p21 [39]. HnRNP proteins (HNRPDL and HNRPA0)
are involved in mRNA processing, metabolism and
transport. PAX8, RELB and two hnRNP genes were all
downregulated by 5 µM quercetin. Many effects have
Table 2 Expression changes of genes involved in apoptosis
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
N51014 apoptotic protease activating factor APAF1 –2.22a –1, 47
T95052 caspase 1 CASP1 –1.81 –1.93*, c
T68892 secreted frizzled related protein 1 SFRP1 –1.74 –1.82a
N48652 Tumor protein p53 binding protein, 2 TP53BP2 1.76*, c 1.31
AA398883 Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3 SERPINB3 1.73*, b 1.65c
AA430512 Serine (or cysteine) proteinase, clade B (ovalbumin), member 9 SERPINB9 2.06*, c 1.86 *, c
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01
Table 3 Expression changes of tumor suppressor genes and oncogenes
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
H48122 Breast cancer 2, early onset BRCA2 1.86a 1.73b
AA857748 Mucin 2, intestinal/tracheal MUC2 1.78*, a 2.23*, c
AA670215 Tumor susceptibility gene 101 TSG101 1.68b 1.65
AA486280 Tissue inhibitor of metalloproteinase 2 TIMP2 1.53 1.79*, c
AA464600 v-myc myelocytomatosis viral oncogene homolog (avian) MYC 1.46 2.01*, c
AA130584 Carcinoembryonic antigen-related cell adhesion molecule 5 CEACAM5 –3.04*, b 1.51
H94892 V-ral simian leukemia viral oncogene homolog A (ras related) RALA –2.10a –1.80c
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01
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been described for EGR1, ranging from growth stimula-
tion to growth suppression and from anti-apoptotic to
pro-apoptotic [40].EGR1 can interact with nuclear tran-
scription factor and tumor suppressor p53 [41]. EGR1
was downregulated by 50 µM quercetin. STAT1, down-
regulated by 50 µM quercetin, is involved in regulation
of cell cycle and apoptosis [42]. MITF interacts with
LEF-1, a member of the Wnt-signalling pathway [43]
and can be a target of the p38 MAPK pathway [44].MITF
was upregulated by quercetin.
Three members of the MAPK signal transduction
pathway were downregulated by quercetin, MAP4K1,
MAP3K12 and MAP2K4 (Table 6). These MAP kinases
can activate JNK1, JNK2 and p38. Other downregulated
signal transduction genes include MADH5, SIAH2 and
IFNGR2. MADH5 is a member of the SMAD protein
family, which is involved in transduction of signals from
the TGF-beta pathway. The SIAH pathway is reported to
influence TGF-beta/SMAD signaling [45]. Increased ex-
pression of IFN-gamma receptors, associated with in-
creased IFN-gamma responsiveness, was reported ear-
lier in post-confluent Caco-2 cells [46]. Several
G-protein coupled receptors were upregulated, like
VIPR1 and EDNRB (at 5 µM) and P2RY2 (at 5 and
50 µM), and in addition several regulators of G-protein
signaling were differentially expressed (RGS7, RGS1 and
RGS19IP1). Two interleukin receptors (IL1R1 and IL4R)
were downregulated by 5 µM quercetin.Two members of
the tumor necrosis factor receptor superfamily (TN-
FRSF1B and TNFRSF11B) were upregulated by
quercetin. Interestingly, after exposure to 50 µM
quercetin expression of a protein kinase C isoform
(PRKCQ) was upregulated.
Downregulation of genes involved in energy metab-
olism was found predominantly after exposure to 50 µM
quercetin (Table 7). GALNT1 is involved in glycosyla-
tion. It was recently found that high expression of
GALNT1 in colorectal carcinomas is associated with a
better prognosis [47]. Two vacuolar ATPases
(ATP6V1C1 and ATP6V0B) were also downregulated.
Vacuolar ATPases could have anti-apoptotic effects in
human cancer cells [48]. Interestingly, PDK2 is down-
regulated, but PDK4 is upregulated after exposure to
50 µM quercetin.
Table 4 Expression changes of genes involved in cell adhesion and cell-cell interaction
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
AA485353 Lectin, galactoside-binding, soluble, 3 binding protein LGALS3BP –3.45*, b –2.99*, d
AA036975 Amine oxidase, copper containing 3 (vascular adhesion protein 1) AOC3 –2.97*, c –2.30
AA292676 A disintegrin and metalloproteinase domain 15 (metargidin) ADAM15 –2.63*, b –1.54
H17975 Armadillo repeat gene deletes in velocardiofacial syndrome ARVCF –2.37*, c –1.43
H66158 plakophilin 2 PKP2 –2.20a –2.14*, c
H56349 Fibrinogen-like 2 FGL2 –2.03*, a –1.48
AA457739 Claudin 10 CLDN10 –1.69 –1.81*, c
H54417 Non-metastatic cells 4, protein expressed in NME4 –1.44 –1.71*, c
T46897 Adhesion regulating molecule 1 ADRM1 –1.69*, c
AA489587 Fibronectin 1 FN1 –1.40c 1.39
AA190508 A disintegrin and metalloproteinase domain 12 (meltrin alpha) ADAM12 1.61*, c 1.25
AA676957 Catenin (cadherin-associated protein), a1 (102kD) CTNNA1 1.63b 1.56a
AA400329 Neurofilament 3 (150kD medium) NEF3 1.62*, c 1.69a
AA452840 Fibulin 2 FBLN2 1.53 1.77*, c
R79948 Formyl peptide receptor-like 1 FPRL1 1.42 1.82*, a
R43483 Integrin, alpha 6 ITGA6 1.65*, c
W49619 Cadherin 2, N-cadherin (neuronal) CDH2 1.92a 1.85a
AA136983 Cadherin 11 (OB-cadherin) CDH11 1.80 1.91*, a
AA133469 Cytokeratin 20 KRT20 1.96 1.93*, c
AA875933 EGF-containing fibulin-like extracellular matrix protein 1 EFEMP1 1.85 2.09*, c
H24006 Oligodendrocyte myelin glycoprotein OMG 2.13*, a 2.46*, a
R56774 Bone morphogenetic protein 1 BMP1 2.46 2.08a
H38240 Thrombospondin 2 THBS2 2.25 2.45*, a
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01; d P < 0.001
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Of all genes studied, CYP1A1 was the gene most in-
duced by quercetin in Caco-2 cells (10.6-fold increase
after exposure to 50 µM quercetin). No induction of
CYP1A1 was found after exposure to 5 µM quercetin. In
breast cancer cells quercetin also caused a time- and
concentration-dependent increase in CYP1A1 mRNA
levels [49]. Several membrane proteins were differen-
tially expressed in response to quercetin (data not
shown). Three potassium channel genes were downreg-
ulated, either after exposure to 5 µM quercetin (KCNK3
and KCNQ2) or after exposure to 50 µM quercetin (KC-
NAB1). Expression of two other potassium channels was
upregulated, KCNMB1 after exposure to 5 µM quercetin
and KCNA1 after exposure to 50 µM quercetin. In addi-
tion, four members of the solute carrier family were
downregulated, SLC2A3 and SLC14A1 after exposure to
5 µM quercetin and SLC1A3 and SLC6A8 after exposure
to 50 µM quercetin. The transporter gene ABCC3, also
known as MRP3, was upregulated after exposure to
50 µM quercetin. Induction of MRP3 gene expression
was also found in two human colon cancer cell lines af-
ter exposure to a NSAID [50].
Expression of CDK4, RALA and CYP1A1 was also
measured by real-time RT-PCR to verify the expression
alterations measured by microarray analysis. Downreg-
ulation of expression of CDK4 by quercetin was con-
firmed by real-time RT-PCR experiments (Fig. 1a).Real-
time PCR showed a stronger downregulation of CDK4
by 5 µM quercetin than the weak non-significant down-
regulation found in the microarray experiment. Down-
regulation of expression of RALA was also found in the
real-time RT-PCR experiments (Fig. 1b). However, when
expression of RALA was normalized using GAPDH ex-
pression, downregulation of RALA by 50 µM quercetin
was not significant. Upregulation of CYP1A1 gene ex-
pression was confirmed by real-time RT-PCR. Interest-
ingly, the induction of CYP1A1 gene expression by
50 µM quercetin, which was ~10-fold in the microarray
experiment, was much higher in the real-time RT-PCR
experiment (~600-fold when normalized to beta-actin
and ~800-fold when normalized to GAPDH, data not
shown).
The gene expression data indicate a marked effect of
quercetin on cell cycle. This was studied in more detail.
After 48 hours exposure to quercetin, no cytotoxicity
was observed in Caco-2 cells at either concentration. Ex-
posure to 5 µM quercetin resulted in a significant de-
crease in cell proliferation (87.4 ± 7.7 % of control;
Table 5 Expression changes of genes involved in transcription
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
AA490538 Zinc finger protein 161 homolog (mouse) ZFP161 –3.40*, c –2.46*, a
AA405767 Paired box gene 8 PAX8 –3.42a –1.81
AA489785 Nuclear receptor coactivator 1 NCOA1 –3.18*, b –2.66
AA258001 Transcription factor RELB RELB –3.18*, b –3.02*
AA598578 Heterogeneous nuclear ribonucleoprotein D-like HNRPDL –2.39*, b –1.72
AA419238 Retinoic acid receptor, β RARB –2.20a –1.73
AA432143 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 CITED1 –2.04*, a –2.53*, a
N77807 Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) MLL –1.91 –2.13*, c
AA599176 Heterogeneous nuclear ribonucleoprotein A0 HNRPA0 –1.87a –1.95
AA488075 Signal transducer and activator of transcription 1 STAT1 –1.36 –1.70*, a
AA630017 Transcription elongation factor B (SIII), polypeptide 2 (18kD, elongin B) TCEB2 –1.35 –1.78b
AA486533 Early growth response protein 1 EGR1 –2.07*, d
AA099534 Activated RNA polymerase II transcription cofactor 4 PC4 1.59a 1.39
H91651 GA-binding protein transcription factor, beta subunit 2 (47kD) GABPB2 1.62 2.12*, d
AA150301 TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32 kD TAF9 1.64c 1.47
W96099 Retinoid X receptor-γ RXRG 1.66 1.78*, c
W47015 Ts translation elongation factor, mitochondrial TSFM 1.75c 1.79b
T64905 Paired-like homeodomain transcription factor 2 PITX2 1.87 2.09*, a
AA102068 Heat shock transcription factor 4 HSF4 1.90*, a 1.60
AA454222 Bromodomain, testis-specific BRDT 2.10 2.71*, b
N66177 Microphthalmia-associated transcription factor MITF 2.18*, c 2.49*, c
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01; d P < 0.001
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P < 0.05). Exposure to 50 µM quercetin however resulted
in a much larger decrease in cell proliferation to
51.3 ± 5.1 % of control (P < 0.001). Inhibition of cell pro-
liferation of Caco-2 cells by quercetin showed a biphasic
response, at low quercetin concentrations (0.5–5 µM)
cell proliferation was decreased to about 90 % of control
and at concentrations higher than 10 µM cell prolifera-
tion showed a more profound dose-dependent decrease
(Fig. 2). Cell cycle analysis showed a decrease in the per-
centage of cells in the G1-phase and an increase in the
percentage of cells in the S-phase when cells exposed to
5 µM quercetin were compared to control (Fig. 3). After
exposure to 50 µM quercetin the percentage of cells in
the G1-phase further decreased and the number of cells
in the sub-G1 phase increased (Fig. 3, P < 0.05 compared
to 5 µM quercetin). This indicates that the decrease in
cell proliferation after exposure to 5 µM quercetin could
be due to S-phase arrest and that the additional decrease
in cell proliferation after exposure to 50 µM quercetin
could be due to a shift from cells in the G1-phase to the
sub-G1 phase.
Discussion
This study describes the effects of quercetin on the ex-
pression of 4000 human genes in Caco-2 cells. An inter-
esting observation was the downregulation of many cell
cycle genes after exposure to 5 µM quercetin. It was
shown that this correlated with a modest but significant
decrease in cell proliferation. In addition, flow cytomet-
ric analyses showed a decrease in the percentage of cells
Table 6 Expression changes of genes involved in signal transduction
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
AA053674 Mitogen-activated protein kinase kinase kinase 12 MAP3K12 –2.42a –1.74a
H05140 Regucalcin (senescence marker protein-30) RGN –2.02*, c –3.31
T50313 Mitogen-activated protein kinase kinase kinase kinase 1 MAP4K1 –2.77a
H24326 Regulator of G-protein signalling 7 RGS7 –2.01*, a –2.46
AA293365 Mitogen-activated protein kinase kinase 4 MAP2K4 –2.02*, c –2.39*, c
R24266 Growth factor receptor-bound protein 14 GRB14 –2.26*, c
AA424700 MAD, mothers against decapentaplegic homolog 5 (Drosophila) MADH5 –2.10a –2.14*, c
AA029042 Seven in absentia homolog 2 (Drosophila) SIAH2 –2.14*, b –2.11*, b
AA284492 Tetraspan 3 TSPAN-3 –1.70 –2.03*, d
AA449440 Interferon gamma receptor 2 (interferon gamma transducer 1) IFNGR2 –2.59 –1.91*, c
AA810225 G protein-coupled receptor 30 GPR30 –2.02 –1.88*, a
AA464526 Interleukin 1 receptor, type 1 IL1R1 –2.03a –1.62
H29322 Calcium/calmodulin-dependent protein kinase I CAMK1 –1.62 –1.54a
AA293306 Interleukin 4 receptor IL4R –1.89*, a –1.27
AA017544 Regulator of G-protein signalling 1 RGS1 1.66 1.87*, c
AA779480 Bone morphogenetic protein 8 (osteogenic protein 2) BMP8 1.73b 1.39
H73241 Vasoactive intestinal peptide receptor 1 VIPR1 1.75*, c 1.49
AA150507 Interleukin 1, beta IL1B 1.86*, a 1.65
H28710 Endothelin receptor type B EDNRB 2.18a 1.72*, c
R68106 Fc fragment of IgG, low affinity IIb, receptor for (CD32) FCGR2B 1.87*, c 1.75b
R70505 Purinergic receptor P2Y, G-protein coupled, 2 P2RY2 2.00*, c 1.86a
AA102526 Interleukin 8 IL8 1.38 1.88*, c
R48132 SH3-domain binding protein 2 SH3BP2 1.70*, c 1.97a
H60824 Protein kinase C, theta PRKCQ 1.78 1.99*, c
T99303 Guanine nucleotide binding protein (G protein), α15 (Gq class) GNA15 1.95*, a 2.04*, c
AA434159 regulator of G-protein signalling 19 interacting protein 1 RGS19IP1 1.86 2.20*, b
AA421269 Phosphatidylinositol 4-kinase, catalytic, α-polypeptide PIK4CA 2.13* 2.33*, d
AA150416 Tumor necrosis factor receptor superfamily, member 1B TNFRSF1B 1.96 2.42*, c
AA194983 Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) TNFRSF11B 2.02*, b 1.93a
N53351 Ras-like without CAAX 2 RIT2 2.32*, b
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01; d P < 0.001
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Table 7 Expression changes of genes involved in energy metabolism
Fold up-/down-regulation
Accession Gene name Gene symbol 5 µM quercetin 50 µM quercetin
number
AA680322 NADH dehydrogenase (ubiquinone) 1 α subcomplex, 4 (9kD, MLRQ) NDUFA4 –2.94*, a –4.93
AA706987 UDP-N-acetyl-alpha-D-galactosamine:polypeptide GALNT1 –1.88 –2.94*, a
N-acetylgalactosaminyltransferase 1 (GalNAc-T1)
AA485376 Adenosine monophosphate deaminase 2 (isoform L) AMPD2 –2.05 –2.82a
H29475 Pyruvate dehydrogenase kinase, isoenzyme 2 PDK2 –2.45*, a
H05768 ATPase, H+ transporting, lysosomal 42kD, V1 subunit C, isoform 1 ATP6V1C1 –1.51 –2.05a
AA062805 Succinate dehydrogenase complex, subunit C SDHC –1.70 –1.71*, c
AA457717 ATPase, H+ transporting, lysosomal 21kD, V0 subunit c ATP6V0B –1.25 –1.54b
H08732 Glycogen synthase 1 (muscle) GYS1 1.42*, d 1.62b
AA169469 Pyruvate dehydrogenase kinase, isoenzyme 4 PDK4 2.12 1.99*, c
These genes were differentially expressed in Caco-2 cells in response to quercetin exposure
Values < 0 indicate downregulation, values > 0 indicate upregulation
* Indicates differential expression according to SAM analysis
For all genes identified as differentially expressed a P-value was calculated using a t-test
a P < 0.05; b P < 0.02; c P < 0.01
Fig. 1 a CDK4 gene expression changes in response to quercetin, measured with cDNA microarray (white bars), and measured by real time RT-PCR normalized to beta-
actin expression (grey bars) or to GAPDH expression (black bars). Normalized expression is plotted as mRNA ratio (quercetin/control). Values are mean ± standard deviation
(n = 5). * expression is significantly different from control (P < 0.05). b RALA gene expression changes in response to quercetin, measured with cDNA microarray (white
bars), and measured by real time RT-PCR normalized to beta-actin expression (grey bars) or to GAPDH expression (black bars). Normalized expression is plotted as mRNA
ratio (quercetin/control). Values are mean ± standard deviation (n = 5). * expression is significantly different from control (P < 0.05)
a) b)
Fig. 2 Cell proliferation of Caco-2 cells exposed to quercetin for 48 hours, with
medium refreshment after 24 hours, measured with BrdU incorporation. Prolifera-
tion in cells exposed to solvent control was set to 100 %, values are mean ± stan-
dard deviation (n = 8) Fig. 3 Cell cycle distribution of Caco-2 cells exposed to quercetin for 48 hours, with
medium refreshment after 24 hours, measured with propidium iodide assay. Val-
ues are mean ± standard deviation (n = 4). * significantly different from 0 µM,
P < 0.05; # significantly different from 5 µM, P < 0.05
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in the G1 phase and an increase in the percentage of cells
in the S-phase. This coincided with a downregulation of
CDK4 and cyclin D1 expression by 5 µM quercetin. Sim-
ilar results were reported for resveratrol; this plant
polyphenol decreased cell proliferation of Caco-2 cells,
caused an S-phase arrest and downregulated protein ex-
pression of CDK4 and cyclin D1 dose-dependently [51].
The CDK4/cyclin D complex is active at the transition
from the G1- to the S-phase. Expression of cyclin D1 and
CDK4 was found to be higher in adenomas than in nor-
mal colon mucosa in AOM-treated mice [52]. In addi-
tion, cyclin dependent kinase inhibitor p27 (CDKN1B)
was upregulated after exposure to 5 µM quercetin, al-
though this effect did not meet the selection criteria set
for differential expression. Upregulation of p27 could
have a role in blocking progression through the S-phase
[53]. CDC6 has a role in DNA replication during the S-
phase [54], so the downregulation of this gene by
quercetin could also be related to the S-phase arrest.
Downregulation of CDC6 gene expression was also re-
ported in human prostate cancer cells after exposure to
genistein,a soy isoflavone [55]. In some colon cancer cell
lines quercetin caused a block in G0/G1 phase [56], in
others in G2/M phase [57]. Chalcone, a precursor of
flavonoids, was reported to inhibit transition from the S
to the G2/M phase in colon cancer cells [57].
Exposure of Caco-2 cells to 50 µM quercetin resulted
in a larger decrease in cell proliferation than exposure to
5 µM quercetin (51.3 % of control vs 87.4 % of control).
The percentage of cells in the G1 phase showed an addi-
tional decrease compared to cells exposed to 5 µM
quercetin, at the same time the percentage of cells in the
sub-G1 phase increased. This indicates that the inhibi-
tion of cell proliferation by 50 µM quercetin could partly
be attributed to an increase in the number of apoptotic
cells in the sub-G1 phase. Downregulation of PLK in
SW480 colon cancer cells did not only inhibit cell prolif-
eration, but also induced apoptosis [58]. This suggests
that downregulation of PLK by 50 µM quercetin could be
related to the increase of percentage of cells in the sub-
G1 phase. Similarly, genes like tumor suppressor genes
or other cell cycle related genes could also be involved in
the process of apoptosis, in addition to differentially ex-
pressed genes involved in apoptosis shown in Table 2.
For example TP53BP2, listed in Table 2, has been re-
ported to be involved in both apoptosis [59] and cell cy-
cle arrest [60], and could be involved in the tumor sup-
pressing activity of p53. Also, CEACAM5, listed in
Table 3 (tumor suppressor genes and oncogenes), was
found to be anti-apoptotic in HT29 cells [61]. Further-
more, the level of APAF1 function can be regulated both
at transcriptional and post-translational level [62],
which is an example of the fact that the process of apop-
tosis is for a large part regulated at the protein level, for
example by activation of procaspases [63]. In addition,
it is possible that effects on apoptotic genes are more
specifically found at earlier time points. At concentra-
tions higher than those used in this study, quercetin was
able to induce apoptosis in human colon cancer cells.
Caco-2 cells exposed to 100 µM quercetin for 3 days
showed chromatin condensation, indicating apoptosis
[12]. In another human colon cancer cell line 200 µM
quercetin caused DNA fragmentation [11]. In breast
cancer cells, apoptosis was increased by lower concen-
trations of quercetin (20 µM) after exposure of 24 hours
or longer [64]. Expression of MYC, known as an onco-
gene, was upregulated by 50 µM quercetin. However, in
Caco-2 cells exposed to the non-steroidal anti-inflam-
matory drug (NSAID) indomethacin downregulation of
cell proliferation and induction of apoptosis coincided
with an increase in expression of c-myc, p53 and p27
[65]. The differentiated action of quercetin on the Caco-
2 cell line (subtle effects on cell cycle through gene reg-
ulation and more severe apoptotic/cytotoxic effects at
higher concentrations) as observed in the gene expres-
sion data and flow cytometry,were also confirmed in the
in vitro cell proliferation data, where a biphasic decrease
in cell proliferation was observed.
Recently, changes in gene expression profile during
differentiation of Caco-2 cells were described [66].Some
of the genes differentially expressed in response to
quercetin showed similar expression changes during
Caco-2 differentiation, for example CDC6 (downregu-
lated), cyclin D1 (downregulated), DNA polymerase al-
pha and delta (downregulated), M phase phosphopro-
tein 1 (downregulated), hnRNP genes (downregulated),
ABCC3 (upregulated), BMP1 (upregulated), fibronectin
1 (downregulated). This was more pronounced at the
lower quercetin concentration, indicating that quercetin
possibly can promote differentiation of Caco-2 cells.
These effects of quercetin on cell cycle and differen-
tiation, together with the effect on expression of tumor
suppressor genes and metastasis suppressors, support
the anticarcinogenic potential of quercetin in Caco-2
cells. Another mechanism of anti-carcinogenicity could
be increased cell-cell interaction. Both up- and down-
regulation of genes involved in cell adhesion and cell-
cell interaction was found in Caco-2 cells after exposure
to quercetin. Upregulation of alpha-catenin could be an
important mechanism of anti-carcinogenicity since al-
pha-catenin can act as an invasion suppressor [67]. Al-
pha-catenin expression in colon cancer cells is associ-
ated with an inhibition of TCF-dependent transcription
[68]. Also, overexpression of plakophilin 2 in SW480
cells (human colon carcinoma cell line) caused an in-
crease in β-catenin/TCF signaling [69]. This indicates
that upregulation of alpha-catenin expression and
downregulation of plakophilin 2 expression could result
in decreased beta-catenin/TCF signaling. The beta-
catenin/TCF signaling pathway, which is a part of the
Wnt signaling cascade, is often deregulated in colon can-
cer [70]. SFRP1, downregulated by 50 µM quercetin, can
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also influence the Wnt signaling pathway [71]. Other
genes that were differentially expressed in response to
quercetin and that are involved in beta-catenin/TCF sig-
naling include MITF and SIAH1. Quercetin influenced
more signal transduction pathways at the gene expres-
sion level. Several genes involved in TGF-beta/SMAD
signal transduction (BMP1, BMP8, MADH5) and in
MAPK signal transduction (MAP2K4, MAP3K12 and
MAP4K1) were differentially expressed.
Although at protein level quercetin and other
flavonoids are known as potent protein kinase C (PKC)
inhibitors [72], quercetin upregulated gene expression
of a protein kinase C isoform in Caco-2 cells. Upregula-
tion of PKC increased cell-cell adhesion in alpha-catenin
negative human colon cancer cells [73]. Also, in another
human colon cancer cell line (HT29) overexpression of
PKC isoform resulted in inhibition of growth and re-
duced tumorigenicity [74]. This indicates that PKC
could act as a growth-suppressor in human colon cancer
cells.
So, in addition to the effect on cell cycle, other leads
obtained by this multiple gene expression experiment to
study in more detail include the effect of quercetin on
beta catenin/TCF signaling since this is an important
pathway in colon carcinogenesis. Another interesting
lead could be transcription factors influenced by
quercetin. In this study, several transcription factors
with target genes that are known to play a role in car-
cinogenesis were differentially expressed in response to
quercetin.
Some genes that were differentially expressed are in-
dicated to be involved in processes or tissues that are not
yet known to be relevant to in vitro cultured colon can-
cer cells. On the one hand, this indicates the partly de-
differentiated character of Caco-2 cells. On the other
hand, such findings stress the importance of data evalu-
ation and call for care in too straightforward biological
interpretation of these microarray data.Therefore,apart
from the careful selection of differentially expressed
genes applied to the data, also pathway-related evalua-
tion was applied and found to be an effective tool in mi-
croarray data analysis. Although in vitro systems by
their very nature are limited in their comparison to the
in vivo situation, it is clear that gene expression studies
using microarrays in combination with functional stud-
ies of cell proliferation and apoptosis can yield a broad
range of interesting information on the mechanisms of
food components in intestinal carcinogenesis.
Several studies report physiological effects of
quercetin in cultured colon cancer cells after an expo-
sure period of 48 hours [12, 13].A similar exposure time
was chosen in this study, however after 24 hours fresh
medium with quercetin was added, to mimic repeated
exposure in the in vivo situation. In future studies, it
would be interesting to measure expression changes at
more and earlier time points, also because gene expres-
sion changes can occur already after short-term expo-
sure. By studying time-dependent changes in expres-
sion, information on effects of quercetin can be further
extended.
In conclusion, this study shows the broad range of ef-
fects at gene expression level that quercetin exerts on
colon cancer cells in vitro. Differential expression of
many cell cycle genes together with the cell cycle arrest
in response to quercetin indicate that quercetin specifi-
cally influences cell proliferation in Caco-2 cells at a low
concentration. Additionally, differential expression of
the genes involved in tumor suppression, cell adhesion,
transcription and signal transduction were found. All
these processes can contribute to the anticarcinogenic
potential of quercetin. In this study all selected differen-
tially expressed genes were studied individually and
grouped according to function of the gene. Each func-
tional group corresponds to one or more pathways. Us-
ing this approach,‘new’ genes were found to be differen-
tially expressed in response to quercetin and by
grouping these genes an indication of pathways involved
in the actions of quercetin was presented.
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